VRG-145
Migraine Prophylaxis
Phase 1Active (Partnered with Novamigra Therapeutics)
Key Facts
Indication
Migraine Prophylaxis
Phase
Phase 1
Status
Active (Partnered with Novamigra Therapeutics)
Company
About VRG Therapeutics
VRG Therapeutics is a private, pre-clinical stage biotech based in Budapest, Hungary, specializing in AI-powered miniprotein drug discovery. The company's core technology platform, comprising ISEP™ and CREATe™, enables the rapid design and optimization of therapeutic peptides with sub-nanomolar affinity and extreme selectivity. While initially targeting neurodegenerative diseases, VRG's versatile platform supports a diverse pipeline and collaborations in cell and gene therapy, positioning it to address high-value, undrugged targets. The company appears to be in a growth phase, securing grants, expanding its team, and initiating an international roadshow.
View full company profileTherapeutic Areas
Other Migraine Prophylaxis Drugs
| Drug | Company | Phase |
|---|---|---|
| INMEST | Abilion Medical Systems | Unknown |